Program and Abstracts from the Canadian Digestive Diseases Week 2016

Table 46

Patients response to infliximab induction.

	Clinical Response, (%)	Clinical Remission, (%)	Primary non-response, (%)
All ()	90 (72)	72 (58)	35 (28)
SR
Intensified ()	34 (90)	27 (71)^#	4 (10)
Standard ()	23 (64)	18 (50)	13 (36)
SD
Intensified ()	9 (64)	7 (50)	5 (36)
Standard ()	24 (65)	20 (54)	13 (35)

versus standard.
versus standard.